Globus Medical Statistics
Total Valuation
Globus Medical has a market cap or net worth of $12.31 billion. The enterprise value is $11.80 billion.
| Market Cap | 12.31B |
| Enterprise Value | 11.80B |
Important Dates
The next confirmed earnings date is Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Globus Medical has 135.67 million shares outstanding. The number of shares has decreased by -0.59% in one year.
| Current Share Class | 113.24M |
| Shares Outstanding | 135.67M |
| Shares Change (YoY) | -0.59% |
| Shares Change (QoQ) | +0.87% |
| Owned by Insiders (%) | 17.00% |
| Owned by Institutions (%) | 83.88% |
| Float | 112.34M |
Valuation Ratios
The trailing PE ratio is 23.15 and the forward PE ratio is 20.29. Globus Medical's PEG ratio is 2.11.
| PE Ratio | 23.15 |
| Forward PE | 20.29 |
| PS Ratio | 4.19 |
| Forward PS | 3.77 |
| PB Ratio | 2.68 |
| P/TBV Ratio | 5.14 |
| P/FCF Ratio | 20.91 |
| P/OCF Ratio | 16.34 |
| PEG Ratio | 2.11 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.45, with an EV/FCF ratio of 20.04.
| EV / Earnings | 21.94 |
| EV / Sales | 4.02 |
| EV / EBITDA | 13.45 |
| EV / EBIT | 19.66 |
| EV / FCF | 20.04 |
Financial Position
The company has a current ratio of 4.26, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.26 |
| Quick Ratio | 2.61 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.13 |
| Debt / FCF | 0.20 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 12.29% and return on invested capital (ROIC) is 12.91%.
| Return on Equity (ROE) | 12.29% |
| Return on Assets (ROA) | 7.11% |
| Return on Invested Capital (ROIC) | 12.91% |
| Return on Capital Employed (ROCE) | 12.49% |
| Weighted Average Cost of Capital (WACC) | 10.16% |
| Revenue Per Employee | $489,822 |
| Profits Per Employee | $89,645 |
| Employee Count | 6,000 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 1.32 |
Taxes
In the past 12 months, Globus Medical has paid $67.20 million in taxes.
| Income Tax | 67.20M |
| Effective Tax Rate | 11.11% |
Stock Price Statistics
The stock price has increased by +24.64% in the last 52 weeks. The beta is 1.09, so Globus Medical's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | +24.64% |
| 50-Day Moving Average | 90.19 |
| 200-Day Moving Average | 76.56 |
| Relative Strength Index (RSI) | 47.42 |
| Average Volume (20 Days) | 1,032,644 |
Short Selling Information
The latest short interest is 3.31 million, so 2.44% of the outstanding shares have been sold short.
| Short Interest | 3.31M |
| Short Previous Month | 3.29M |
| Short % of Shares Out | 2.44% |
| Short % of Float | 2.95% |
| Short Ratio (days to cover) | 3.13 |
Income Statement
In the last 12 months, Globus Medical had revenue of $2.94 billion and earned $537.87 million in profits. Earnings per share was $3.92.
| Revenue | 2.94B |
| Gross Profit | 2.00B |
| Operating Income | 600.27M |
| Pretax Income | 605.07M |
| Net Income | 537.87M |
| EBITDA | 877.11M |
| EBIT | 600.27M |
| Earnings Per Share (EPS) | $3.92 |
Balance Sheet
The company has $557.24 million in cash and $119.44 million in debt, giving a net cash position of $509.62 million or $3.76 per share.
| Cash & Cash Equivalents | 557.24M |
| Total Debt | 119.44M |
| Net Cash | 509.62M |
| Net Cash Per Share | $3.76 |
| Equity (Book Value) | 4.57B |
| Book Value Per Share | 33.86 |
| Working Capital | 1.63B |
Cash Flow
In the last 12 months, operating cash flow was $753.45 million and capital expenditures -$164.68 million, giving a free cash flow of $588.77 million.
| Operating Cash Flow | 753.45M |
| Capital Expenditures | -164.68M |
| Depreciation & Amortization | 276.84M |
| Net Borrowing | -449.99M |
| Free Cash Flow | 588.77M |
| FCF Per Share | $4.34 |
Margins
Gross margin is 68.07%, with operating and profit margins of 20.42% and 18.30%.
| Gross Margin | 68.07% |
| Operating Margin | 20.42% |
| Pretax Margin | 20.59% |
| Profit Margin | 18.30% |
| EBITDA Margin | 29.84% |
| EBIT Margin | 20.42% |
| FCF Margin | 20.03% |
Dividends & Yields
Globus Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.59% |
| Shareholder Yield | 0.59% |
| Earnings Yield | 4.37% |
| FCF Yield | 4.78% |
Analyst Forecast
The average price target for Globus Medical is $100.42, which is 10.67% higher than the current price. The consensus rating is "Buy".
| Price Target | $100.42 |
| Price Target Difference | 10.67% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 7.62% |
| EPS Growth Forecast (5Y) | 12.02% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Globus Medical has an Altman Z-Score of 9.47 and a Piotroski F-Score of 7.
| Altman Z-Score | 9.47 |
| Piotroski F-Score | 7 |